Artwork
iconShare
 
Manage episode 444173842 series 2480277
Content provided by National Psoriasis Foundation. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by National Psoriasis Foundation or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Over 20 years ago biologics were introduced for psoriasis and PsA. Since then even more targeted treatments have been introduced. Listen as dermatologist Dr. Steven Feldman from Wake Forest University School of Medicine, shares his perspectives on the latest treatments, resident memory T-cells, and what's to come (such as an oral IL-23 agent) with moderator Max Blitstein. This episode is provided with support from Bristol Myers Squibb.

  continue reading

212 episodes